Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation.
- Published in:
- Molecular Biology Reports, 2025, v. 52, n. 1, p. 1, doi. 10.1007/s11033-024-10146-y
- By:
- Publication type:
- Article
Works by Murtaza, Asad
Results: 6
1
2
Lipoprotein Signal Peptide as Adjuvants: Leveraging Lipobox-Driven TLR2 Activation in Modern Vaccine Design.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 36, doi. 10.3390/vaccines13010036
- By:
- Publication type:
- Article
3
Advancing PEDV Vaccination: Comparison between Inactivated and Flagellin N-Terminus-Adjuvanted Subunit Vaccines.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 139, doi. 10.3390/vaccines12020139
- By:
- Publication type:
- Article
4
Recent Global Trends in Vaccinology, Advances and Challenges.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 520, doi. 10.3390/vaccines11030520
- By:
- Publication type:
- Article
5
Flagellin Improves the Immune Response of an Infectious Bursal Disease Virus (IBDV) Subunit Vaccine.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1780, doi. 10.3390/vaccines10111780
- By:
- Publication type:
- Article
6
Utilizing NF-κB Signaling in Porcine Epithelial Cells to Identify a Plant-Based Additive for the Development of a Porcine Epidemic Diarrhea Virus Vaccine.
- Published in:
- Veterinary Sciences, 2025, v. 12, n. 2, p. 181, doi. 10.3390/vetsci12020181
- By:
- Publication type:
- Article